Atopic dermatitis research has expanded rapidly with biologic and small-molecule therapies. Dupilumab set the standard, and now trials test next-generation biologics targeting IL-13, IL-31 (itch-specific), and OX40 pathways. Oral JAK inhibitors like abrocitinib and upadacitinib are studied in long-term extension trials. Topical treatments including tapinarof and roflumilast cream offer steroid-free options. Microbiome transplant studies explore whether restoring healthy skin bacteria can reduce flares. Trials are available for mild, moderate, and severe atopic dermatitis in both adults and children. If over-the-counter treatments and prescriptions have not controlled your eczema, a clinical trial may provide relief.
Neurological
Atopic Dermatitis: New Clinical Trial Treatments
Quick Answer
New atopic dermatitis clinical trials are testing JAK inhibitors, IL-13 and IL-31 antibodies, topical PDE4 inhibitors, and microbiome-based therapies that go beyond traditional steroids to target the root causes of eczema flares.
Take the Next Step
Find clinical trials that match your condition, location, and treatment preferences.